About Twister Biotech
Twister Biotech is a private company based in Houston, Texas. It has reported $1,615,305 raised in two offerings on Form D since January 2021. Its chief executive is Christopher Coker.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 25, 2023 | Aug 28, 2023 | $500,000of $2.0M target | 2 | $250K | Equity, DebtRule 506(b) | Form D ↗ |
| Dec 23, 2020 | Jan 11, 2021 | $1,115,305of $3.0M target | 2 | $557K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $1,615,305 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Twister Biotech's Form D filed Aug 28, 2023.
ED
Evan Davies
Director
MP
Michael Pavia
Director
CC
Christopher Coker
CEO and President, director
AS
Alex Steven
Executive officer and director
Earlier filings also listed Mark Matovich (director, last listed Jan 2021) and Lynn Zechiedrich (executive officer and director, last listed Jan 2021).